Acute fetal leukemia: When should it be suspected? What assessment should be performed? A case series and review of literature
- PMID: 38923613
- DOI: 10.1002/pd.6630
Acute fetal leukemia: When should it be suspected? What assessment should be performed? A case series and review of literature
Abstract
Introduction: Acute fetal leukemia is rare and characterized by a very poor prognosis. The aims of this study were to identify cases of acute fetal leukemia and to describe ultrasound and fetopathological findings that should lead to a suspicion of this diagnosis, as well as the investigations required to confirm it.
Methods: A national retrospective study was conducted. Clinical data, prenatal ultrasounds and postmortem findings of fetal acute leukemia cases were collected and analyzed.
Results: We collected seven cases: four in utero fetal deaths, two neonatal deaths and one termination of pregnancy. Prenatal ultrasounds showed fetal hydrops (42.9%) associated with hepatosplenomegaly (100%). In addition, post-mortem examination (n = 6) suggested a Down syndrome in one case and showed other organomegaly (83.3%) due to blastic infiltration, mainly in the liver, along with extrahepatic multivisceral hematopoiesis. Immunostainings allowed to specify the type of leukemia (71.4%). In one case, diagnosis was made on blood smear and flow cytometry was performed on fresh blood samples. All cases corresponded to acute myeloid leukemia. Karyotype was abnormal in 4 cases (66.7%), including one free trisomy 21, two mosaic trisomy 21 and one chromosome 15 deletion. GATA1 gene mutations were identified in two cases: one mosaic trisomy 21 and one with normal karyotype.
Conclusion: Any hepatosplenomegaly associated with fetal hydrops and a negative immune, infectious, and metabolic work-up, should suggest acute fetal leukemia and prompt additional investigations.
© 2024 John Wiley & Sons Ltd.
References
REFERENCES
-
- Kar A, Hijiya N. Diagnosis and initial management of pediatric acute leukemia in the emergency department setting. Clin Pediatr Emerg Med. 2018;19(2):135‐144. https://doi.org/10.1016/j.cpem.2018.05.003
-
- Fouché C, Ramos A, Esperandieu O, Briault S, Martin J.‐G, Desroches A. Fetal hepatosplenomegaly in the third trimester: a sign of leukemia in fetuses with Down syndrome. J Gynecol Obstet Biol Reprod. 2010;39(8):667‐671. https://doi.org/10.1016/j.jgyn.2010.06.002
-
- Kim GJ, Lee ES. Prenatal diagnosis of transient abnormal myelopoiesis in a Down syndrome fetus. Korean J Radiol. 2009;10(2):190‐193. https://doi.org/10.3348/kjr.2009.10.2.190
-
- Robertson M, De Jong G, Mansvelt E. Prenatal diagnosis of congenital leukemia in a fetus at 25 weeks’ gestation with Down syndrome: case report and review of the literature. Ultrasound Obstet Gynecol. 2003;21(5):486‐489. https://doi.org/10.1002/uog.87
-
- Sato Y, Izumi Y, Minegishi K, et al. Prenatal findings in congenital leukemia: a case report. Fetal Diagn Ther. 2011;29(4):325‐330. https://doi.org/10.1159/000323582
LinkOut - more resources
Full Text Sources